RT Journal Article
SR Electronic
T1 One-Year Data from the RESOLUTE US Trial
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 3
SP 14
OP 15
DO 10.1177/155989771103005
UL http://mdc.sagepub.com/content/11/3/14.abstract
AB Drug-eluting stents (DES) are commonly used to treat coronary artery disease, because they reduce in-stent thrombosis and the need for repeat revascularization compared with bare-metal stents. However, there are safety concerns regarding the infrequent but life-threatening complication of stent thrombosis. Further development of DES with sustained drug release is hypothesized to represent an even safer alternative.